Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Discussion of the entities and frameworks responsible for enforcing index rules and governance, including accountability and compliance checks.
28,655 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Chart Industries just delivered a sweeping earnings milestone, but a sizable investor trimmed a multi-million dollar ...
In March 2026, traders are weighing CenterPoint Securities alternatives as costs diverge and platforms upgrade featur...
Dollar Tree has reshaped its business with store expansion and a strategic divestment. This guide explains why you mi...
The mood around U.S. housing is shifting. Prices, rents, and mortgage costs are moving in ways that could change how ...
Markets have bounced, but a few names still stand out as compelling buys. Here are three stocks you'll regret not own...
A year of blistering gains can blur rational thinking. This infrastructure stock 570% rally prompts a careful plan: s...
When headlines shift at the Fed, markets tend to move fast. This piece breaks down how Warsh becoming Fed Chair could...
When lululemon shares dropped after the company cut its annual forecast, it sent a clear message about the market's g...
Starting a life together means budgeting tips for young couples matter more than ever. This guide gives you actionabl...
A clear, actionable look at beyond (xair) 2026 earnings and what a Q4 earnings call could reveal. Learn how to read t...
When memory prices surge and Micron raises guidance, MU stock attention swells. This article deciphers the impulse be...